[HTML][HTML] Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments

CA Maronese, MA Pimentel, MM Li… - American Journal of …, 2022 - Springer
Pyoderma gangrenosum is a rare inflammatory skin disease classified within the group of
neutrophilic dermatoses and clinically characterized by painful, rapidly evolving cutaneous …

Pyoderma gangrenosum

E Maverakis, AV Marzano, ST Le, JP Callen… - Nature Reviews …, 2020 - nature.com
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly
developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema …

ROC and AUC with a binary predictor: a potentially misleading metric

J Muschelli III - Journal of classification, 2020 - Springer
In analysis of binary outcomes, the receiver operator characteristic (ROC) curve is heavily
used to show the performance of a model or algorithm. The ROC curve is informative about …

[HTML][HTML] Pyoderma gangrenosum–a guide to diagnosis and management

C George, F Deroide, M Rustin - Clinical Medicine, 2019 - Elsevier
Pyoderma gangrenosum (PG) is a reactive non-infectious inflammatory dermatosis falling
under the spectrum of the neutrophilic dermatoses. There are several subtypes, with …

Extraintestinal manifestations in inflammatory bowel disease–epidemiology, genetics, and pathogenesis

T Greuter, SR Vavricka - Expert review of gastroenterology & …, 2019 - Taylor & Francis
Introduction: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily
of, but not restricted to the gut. Extraintestinal manifestations (EIMs) are frequently observed …

The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata

N Meah, D Wall, K York, B Bhoyrul, L Bokhari… - Journal of the American …, 2020 - Elsevier
Background A systematic review failed to identify any systemic therapy used in alopecia
areata (AA) where use is supported by robust evidence from high-quality randomized …

Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn “der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten …

A Sturm, R Atreya, D Bettenworth… - Zeitschrift für …, 2022 - thieme-connect.com
Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …

[HTML][HTML] Consensus criteria for the diagnosis of scabies: a Delphi study of international experts

D Engelman, LC Fuller, AC Steer… - PLoS neglected …, 2018 - journals.plos.org
Background Scabies was added to the WHO Neglected Tropical Diseases portfolio in 2017,
and further understanding of the disease burden is now required. There are no uniformly …

[HTML][HTML] A machine learning model for accurate prediction of sepsis in ICU patients

D Wang, J Li, Y Sun, X Ding, X Zhang, S Liu… - Frontiers in public …, 2021 - frontiersin.org
Background: Although numerous studies are conducted every year on how to reduce the
fatality rate associated with sepsis, it is still a major challenge faced by patients, clinicians …

Therapeutic potential of targeting interleukin‐1 family cytokines in chronic inflammatory skin diseases

L Calabrese, Z Fiocco, TK Satoh… - British Journal of …, 2022 - academic.oup.com
Summary The interleukin (IL)‐1 family of cytokines is a central regulator of a myriad of
immunological responses. It comprises several cytokines, including those belonging to the …